 |
12 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- |||||||||| Retuxira (rituximab biosimilar) / 3SBio
New P3 trial, Combination therapy: Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma (clinicaltrials.gov) - Oct 17, 2011
P3, N=278, Completed, Sponsor: Shanghai CP Guojian Pharmaceutical Co.,Ltd.